Skip to main content
. 2021 Nov 18;34(4):576–583. doi: 10.1093/icvts/ivab294

Table 3:

The MGFA-PIS of patients after thymectomy

MGFA-PIS Overall (n = 134) STT (n = 64) UTT (n = 70) P-value
Effective, n (%) 117 (87.3) 55 (85.9) 62 (88.6) 0.985
 CSR 41 (30.6) 20 (31.2) 21 (30.0)
 PR 32 (23.9) 15 (23.4) 17 (24.3)
 MM 30 (22.4) 14 (21.9) 16 (22.9)
 I 14 (10.4) 6 (9.4) 8 (11.4)
Ineffective, n (%) 17 (12.7) 9 (14.1) 8 (11.4) 0.997
 U 9 (6.7) 5 (7.8) 4 (5.7)
 W 4 (3.0 2 (3.1) 2 (2.9)
 E 2 (1.5) 1 (1.6) 1 (1.4)
 D 2 (1.5) 1 (1.6) 1 (1.4)

Effective: CSR + PR + MM + I; Ineffective: U + W + E + D.

CSR: complete stable remission; D: death; E: exacerbation; I: improved; MM: minimal manifestation; PIS: post-intervention status; PR: pharmacological remission; STT: subxiphoid-subcostal thoracoscopic thymectomy; U: unchanged; UTT: uilateral thoracoscopic thymectomy; W: worse.